Health Care Clinic Team

ACTG 5243 (BioBanK)

Plan for Obtaining Human Biological Samples at Non-U.S. Clinical Research Sites for Currently Unspecified Genetic Analyses

ACTG 5324 (InMIND)

A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification with Maraviroc and Dolutegravir with no Intensification or Intensification with Dolutegravir alone for the Treatment of Cognitive Impairment in HIV

ACTG 5332

Randomized Trial to Prevent Vascular Events in HIV – REPRIEVE (A5332)

ACTG 5360 (MINMON)

A Single-arm Study to Evaluate the Feasibility and Efficacy of a Minimal Monitoring Strategy to Deliver Pan-genotypic Ribavirin-free HCV Therapy to HCV Infected Populations who are HCV Treatment Naïve with Evidence of Active HCV Infection: The MINMON Study

ACTG 5375

An Open-Label, Phase II Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination with Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy

MK1439A-021  (DRIVE-AHEAD)

phase III multicenter, double-blind, randomized, active comparator-controlled clinical trial to evaluate the safety and efficacy of MK-1439A once-daily versus ATRIPLA once-daily in treatment-naïve HIV-1 infected subjects

Neuro Fellow ID

การศึกษาการเพิ่มขึ้นของการทำงานของระบบประสาทและการรับรู้หลังจากเปลี่ยนจากยาเอฟฟาไวเรนซ์เป็นยาริวพิไวรีน ในผู้ติดเชื้อเอชไอวีผู้ใหญ่แบบสุ่มเปรียบเทียบ